Armata Pharmaceuticals (ARMP) Capital Expenditures: 2013-2024
Historic Capital Expenditures for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to $1.9 million.
- Armata Pharmaceuticals' Capital Expenditures rose 2072.22% to $391,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $597,000, marking a year-over-year increase of 929.31%. This contributed to the annual value of $1.9 million for FY2024, which is 76.93% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Capital Expenditures of $1.9 million as of FY2024, which was down 76.93% from $8.1 million recorded in FY2023.
- In the past 5 years, Armata Pharmaceuticals' Capital Expenditures ranged from a high of $8.1 million in FY2023 and a low of $824,000 during FY2020.
- Over the past 3 years, Armata Pharmaceuticals' median Capital Expenditures value was $2.2 million (recorded in 2022), while the average stood at $4.1 million.
- Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 268.34% in 2023, then plummeted by 76.93% in 2024.
- Armata Pharmaceuticals' Capital Expenditures (Yearly) stood at $824,000 in 2020, then soared by 58.25% to $1.3 million in 2021, then surged by 69.56% to $2.2 million in 2022, then spiked by 268.34% to $8.1 million in 2023, then crashed by 76.93% to $1.9 million in 2024.